SPIE, The International Society for Optics and Photonics, Announces Its 2021 Society Awards
The Awards Committee of SPIE, the international society for optics and photonics, today announced the recipients of its prestigious annual awards. Honoring transformative advancements in multiple areas — including medicine, astronomy, lithography, optical metrology, and community-focused achievements — the Society's awards recognize technical accomplishments as well as committed service to SPIE and support of its organizational mission.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210112005279/en/
Maryellen Giger, the A.N. Pritzker Professor of Radiology at the University of Chicago, is recognized with the 2021 SPIE Directors' Award. (Photo: Business Wire)
SPIE Gold Medal: Hugo Thienpont
In recognition of his profound and durable impact on society and pioneering vision for photonics. The different disruptive instruments that Thienpont has developed and implemented during the past decades have generated a tangible impact on education, research, innovation, and societal well-being in Flanders, across Europe, and beyond.
SPIE President's Award: Maria Yzuel
In recognition of her inspirational leadership in the field of optics; tireless dedication to the promotion of equity, diversity, and inclusion in science; and many years of outstanding service to SPIE and its international community.
SPIE Directors' Award: Maryellen Giger
In recognition of her outstanding service to SPIE and the optics and photonics communities. Giger has been a key voice in data-driven approaches, and an active leader in pushing forward our equity, diversity, and inclusion efforts.
SPIE Mozi Award: Xiang Zhang
In recognition of his seminal, fundamental contributions in optical physics and experimental research in the optical perfect lens.
SPIE Britton Chance Award in Biomedical Optics: Enrico Gratton
In recognition of a lifetime of contributions to the field of biomedical optics, including pioneering theoretical and instrumentation developments in fluorescence spectroscopy, fluorescence microscopy, and diffuse medical imaging.
SPIE Biophotonics Technology Innovator Award: Keisuke Goda
In recognition of his significant contributions to the field of biophotonics through the development of innovative ultrafast optical imaging and spectroscopy methods and their integration into microfluidic platforms.
SPIE A.E. Conrady Award in Optical Engineering: Dave Aikens
In recognition of his world-leading expertise, training programs, and development of optical engineering and optical standards.
SPIE Harrison H. Barrett Award in Medical Imaging: Kevin Berbaum
In recognition of more than three decades of dedication in the study of Satisfaction of Search, and significant contributions to receiver operating characteristic analysis.
SPIE Harold E. Edgerton Award in High-Speed Optics: Vladislav Yakovlev
In recognition of his remarkable contributions to ultrafast laser technology, ultrafast spectroscopies, and ultrafast imaging and their applications, as well as for his SPIE outreach.
SPIE Dennis Gabor Award in Diffractive Optics: Małgorzata Kujawińska
In recognition of her outstanding and manifold contributions to holographic technologies in optical metrology, optical imaging, and optical information processing, as well as for her extraordinary dedication to the SPIE community and widely recognized international leadership in applied optical engineering.
SPIE George W. Goddard Award in Space and Airborne Optics: Thomas Rimmele
In recognition of his invention and application of extended-source adaptive optics delivering diffraction-limited, high-resolution imaging of the solar surface.
SPIE G. G. Stokes Award in Optical Polarization: Nirmalya Ghosh
In recognition of his extensive research in the field of Mueller matrix polarimetry and applications of Mueller matrix polarimetric spectroscopy and imaging in various interdisciplinary fields including quantum optics, space optics, biomedical optics, chemistry, material science, and fluorescence spectroscopy.
SPIE Chandra S. Vikram Award in Optical Metrology: Krzysztof Patorski
In recognition of hisseminal contributions to diffraction, interferometry, moiré fields, and fringe analysis with applications in optical metrology, experimental mechanics, and biomedical engineering.
SPIE Frits Zernike Award in Microlithography: Bruce Smith
In recognition of his many contributions as a researcher and leader in the microlithography community, and for his achievements in educating an entire generation of engineers who continue to advance academic research and industry understanding.
SPIE Diversity Outreach Award: Celine d'Orgeville
In recognition of her leadership in diversity, inclusion, and equity activities in Australia and elsewhere in the world.
SPIE Maria Goeppert-Mayer Award in Photonics: Jorge Ojeda-Castañeda
In recognition of his outstanding contributions to modern and advanced imaging technologies for the development of phase-space representations of imaging devices, which enable the design of innovative techniques for extending field depth, and for proposing novel designs employing lenses with tunable optical power.
SPIE Maiman Laser Award: Anne Tropper
In recognition of her pioneering contributions to rare-earth doped fiber and optically pumped semiconductor lasers.
SPIE Early Career Achievement Award — Academic Focus: Muyinatu Bell
In recognition of her pioneering contributions to photoacoustic imaging for surgical guidance, including innovative technology designs, novel deep learning applications, informative spatial coherence beamforming theory, and visionary clinical possibilities.
SPIE Early Career Achievement Award — Industry/Government Focus: Sergio Carbajo
In recognition of his capacity to unify ultrafast and quantum optics with X-ray science to advance the mission of Basic Energy Sciences facilities.
SPIE Maria J. Yzuel Educator Award: Bishnu Pal
In recognition of four decades of sustained contributions in education, outreach, research, technical program committees of global flagship conferences, and editing of four popular publications in guided wave optics and photonics.
SPIE Aden and Marjorie Meinel Technology Achievement Award: Shouleh Nikzad
In recognition of her pioneering and sustained contributions to the development of ultraviolet instrument technologies, especially imagers for space exploration and extension of their use in terrestrial applications.
The complete listing of all SPIE awards and recipients is available here.
SPIE is the international society for optics and photonics, an educational not-for-profit organization founded in 1955 to advance light-based science, engineering, and technology. The Society serves more than 258,000 constituents from 184 countries, offering conferences and their published proceedings, continuing education, books, journals, and the SPIE Digital Library. In 2020, SPIE provided over $5.8 million in community support including scholarships and awards, outreach and advocacy programs, travel grants, public policy, and educational resources. www.spie.org.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Servier announce updated overall survival results of exploratory TASCO1 phase II study of LONSURF ® + bevacizumab in a first-line setting for patients with unresectable mCRC non-eligible for intensive therapy16.1.2021 22:15:00 CET | Press release
Servier announced today updated results from the exploratory phase II TASCO1 study evaluating LONSURF® (trifluridine/tipiracil) + bevacizumab and capecitabine + bevacizumab (C-B) in a first-line setting for patients with unresectable metastatic colorectal cancer (mCRC) who are non-eligible for intensive therapy.1 The data were announced today during an oral presentation at the 2021 ASCO Gastrointestinal Cancers Symposium (ASCO-GI). Patients with mCRC who are not eligible for chemotherapy face a large unmet need, with fewer treatment options available to them and lower survival rates. Colorectal cancer (CRC) makes up 9.7% of total global cancer cases, with almost 1.4 million new cases of CRC each year.2 In Europe, CRC is the second most common cause of death due to cancer, and those with a metastatic disease have a 5-year survival rate of just 11%.3 “For patients with metastatic colorectal cancer, those non-eligible for standard combination therapy have few options left and we are conti
H.I.G. Realty Invests in Production Studios & Content Hub in Madrid15.1.2021 09:00:00 CET | Press release
H.I.G. Capital, LLC ("H.I.G."), a leading global alternative investment firm with $43 billion of equity capital under management, announced today that one of its affiliates has invested in Madrid Content City, an approximately 140,000 square meter hub with state of the art audio-visual facilities, including production studios, production & post-production technical facilities, and a university focused on media studies. H.I.G. continues to add to its sizeable portfolio of real estate assets across Europe, consisting of both equity as well as debt investments, with a particular focus on its target market of value-added small and midcap opportunities. Riccardo Dallolio, Managing Director and Head of H.I.G. Europe Realty Partners, commented: “Madrid Content City will benefit from strong secular tailwinds underpinned by the boom in content production. The state-of-the-art studios and related facilities, the exceptional multinational tenant line-up with long term leases, and its critical mas
Eurofins, the global leader in analytical testing, expands worldwide face mask testing & certification capabilities15.1.2021 07:30:00 CET | Press release
Since the start of the pandemic Eurofins (Paris:ERF) has tested thousands of models of surgical and hygienic masks and provided best-in-class speed and certification for PPEs globally, enabling these critical products to get market as fast as possible. Eurofins has developed global leading testing capabilities and certification services in the North America, Europe and Asia ensuring that PPE manufacturers are able to provide the indispensable support needed in the fight against the coronavirus. As of today, Eurofins is one of the few GLP certified and ISO/IEC 17025 accredited laboratory networks to fully cover all testing requirements for surgical/medical and hygienic masks by the FDA, EU regulations and many international and country-specific directives and guidelines such as CEN, CE Marking, ISO, ASTM or OECD. Our robust portfolio for masks includes globally accepted, safety and performance testing, virucidal, bacterial filtration, particle filtration, differential pressure, biocompa
TOXINS 2021: New analyses of pivotal Phase III trial data highlight long duration of response for Dysport ® (abobotulinumtoxinA) in five therapeutic indications15.1.2021 07:00:00 CET | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced results from new analyses of pivotal Phase III clinical trial data to assess treatment intervals over repeat cycles of Dysport® (abobotulinumtoxinA [aboBoNT-A]) in five patient populations. AbobotulinumtoxinA: Evidence for Long Duration of Response from 5 Patient Populations is being shared during the TOXINS 2021 conference, which is taking place virtually between 16-17 January 2020 and is organized by the International Neurotoxin Association.1-28 Ipsen is sharing 26 abstracts during the congress, with data including updates from the recently published surveys into the experience of patients and caregivers, data from the Phase IV ULIS-III trial, and ten abstracts focused on basic science research into neurotoxins.1-27 Spasticity is one of the most common and disabling conditions associated with many neurological conditions in adults and is characterized by velocity-dependent muscle hypertonia. Spasticity can lead to disabilit
Velodyne Lidar Commends NHTSA Plan to Update NCAP14.1.2021 21:58:00 CET | Press release
Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today commended the U.S. Department of Transportation’s National Highway Traffic Safety Administration (NHTSA) plan to update to its New Car Assessment Program (NCAP). The NHTSA proposal would add four advanced driver assistance system (ADAS) capabilities to the NCAP, keeping pace with evolving safety technologies and providing much-needed information to consumers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210114005992/en/ Images show vehicle with lidar-based PAEB stopping before adult target @ 50% overlap (above) and vehicle with camera and radar-based PAEB crashing into adult target (below). (Photo: Velodyne Lidar, Inc.) NCAP is the U.S. Government’s premier consumer information program for evaluating vehicle safety performance. The NHTSA proposal to add ADAS technologies to the NCAP includes pedestrian automatic emergency braking, lane keeping support, blind spot warning and
Snow Software Recognized as a 2020 Gartner Peer Insights Customers’ Choice for Software Asset Management14.1.2021 20:39:00 CET | Press release
Snow Software, the global leader in technology intelligence, today announced that the company was named a December 2020 Gartner Peer Insights Customers’ Choice for Software Asset Management (SAM) Tools. Gartner defines software asset management tools as technology that “automates many of the tasks required to maintain compliance with software licenses, thereby controlling software spending.” This is the fourth Gartner Peer Insights Customers’ Choice announcement for SAM, and Snow has earned the distinction all four times. Based solely on feedback from verified customers, Gartner Peer Insights Customers’ Choice reflects reviews and ratings published within the last 12 months. Snow received 100 reviews – the most of any vendor in the market – with an overall rating of 4.6 out of 5 as of January 12, 2021. Earlier this year, Snow was recognized as a Leader in Gartner’s 2020 Magic Quadrant for Software Asset Management Tools1 and received the highest scores in three out of four use cases in
Veristat Supported Marketing Applications for 10% of All FDA Novel Drug Approvals in 202014.1.2021 19:15:00 CET | Press release
Veristat, a scientific-minded global clinical research organization (CRO), announced today that they supported the marketing applications for 10% of the 2020 US Food and Drug Administration (FDA) novel drug approvals. The FDA approved 53 novel drugs, defined by the FDA as New Molecular Entities (NMEs)i, and Veristat regulatory, statistical, and medical writing experts were integral in preparing five of these NME New Drug Applications. Veristat also prepared NDA/BLAs for three non-NME FDA approvals and one Marketing Authorization Application (MAA) that received approval in Europe. "Despite the global challenges in 2020, Veristat continued to advance its mission of helping clients achieve regulatory approval of novel medical therapies," stated Patrick Flanagan, Chief Executive Officer at Veristat. "Now, more than ever, Veristat is focused on providing expert guidance to facilitate the rapid approval for therapies that improve the lives of patients and their families around the world." Ve
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom